Wayde McMillan is recorded as CFO at Solventum Corp (SOLV). Solventum Corp reported in an 8-K filed April 4, 2024 that Wayde McMillan was appointed Chief Financial Officer, effective April 1, 2024. The proxy statement of Solventum Corp reports total compensation of $6,165,583 for Wayde McMillan in fiscal 2025, including a base salary of $773,229. Disclosed compensation is on record for 2 fiscal years. Wayde McMillan has spoken on 6 earnings calls across 1 company, most recently for Solventum Corp on November 5, 2026. Solventum Corp is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Solventum Corp includes Carrie S. Cox (Chairman and Board Member), Amy Landucci (CIO), Marcela Kirberger (General Counsel) and 7 others.
“In connection with the Distribution, as of the Effective Time, all of the executive officers of Solventum were removed and the following individuals became executive officers of Solventum, with the titles set forth in the table below:”
Solventum Corp Form 8-K, filed April 4, 2024
· Read the filing
Wayde McMillan on recent calls
“We delivered another solid quarter in Q3, as we continue to execute our strategic and financial plans. Consistent with prior quarters, we'll provide a progress update on our separation from 3M and portfolio actions, then transition to third quarter financial results, and conclude with an update on our 2026 guidance.”
“Okay, said simply, we're building a more focused, a more disciplined company, one that is well positioned to deliver sustainable growth margin expansion and shareholder value and with that i'm going to turn it over to wait okay wait go ahead thanks brian we delivered another solid quarter in q2 with continued momentum…”
“We're off to a great start in 2026, delivering first quarter results that were ahead of our plan and expectations on both sales and earnings. As usual, I'll begin with an update on separation progress and portfolio actions, then walk through the quarter and conclude with a review of full-year outlook.”
“We reported another solid quarter as we completed our first full year as an independent public company we made progress across both our transformation phases and turning around the business our commercial improvements yielded a significant increase in our organic sales growth putting us on an accelerated path to reach…”
“Thanks, Bryan, and thanks to everyone at Solventum for the extra effort to separate from 3M and position us to report a strong second quarter as a public company.”
